Hill Top Research positions itself for growth

By Kirsty Barnes

- Last updated on GMT

Related tags: Clinical research services, Finance, Clinical trial

Hill Top Research, one of the leading clinical research services
companies in the US, has positioned itself for growth after last
week's acquisition by Utah's DW Healthcare Partners, a private
equity firm focused on the healthcare industry.

The acquisition, financed with $8 million in equity from >DWHP​ and additional debt financing from a third party provider, will allow Hill Top to expand capacity within the pharmaceutical services market, add new technical capabilities, and provide the funds for possible industry acquisitions, according to the company.

The new company will be called Hill Top Acquisition Corp. and will continue to do business as >Hill Top Research,​ offering a range of clinical research services, including safety testing, efficacy testing, sensory testing, claim substantiation, data management, project management, and microbiology.

"This investment enhances our ability to continue to offer clinical research expertise and subject recruiting at our multiple locations throughout North America. In addition, we can continue to invest in providing high quality clinical studies for our clients," said Joel Ivers, Hill Top COO.

In conjunction with the acquisition announcement, Hill Top also announced that its CEO of 20 years, Jim Pearce, has now retired and will be replaced by current COO Joel Ivers.

Related news

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

Related suppliers

Follow us


View more